Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMINOS: Amino Acids for Hepatic Fat in Adolescents
NCT05935826Phase 3Completed
- Sponsor
- University of Colorado Denver
- Start
- Jun 2024
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in non-alcoholic fatty liver disease (NAFLD) (2 arms), sponsored by University of Colorado Denver. Primary endpoint: Change in Hepatic Fat Fraction at 8 weeks. Started Jun 2024; status: completed.
02
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT05935826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05935826.